Issued Patents 2022
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11535607 | Isoindolines as HDAC inhibitors | Xiaozhang Zheng, Matthew W. Martin, Pui Yee Ng, Jennifer R. Thomason, Bingsong Han +1 more | 2022-12-27 |
| 11498913 | Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors | Jian Lin, Anna Ericsson, Ann-Marie Campbell, Gary Gustafson, Zhongguo Wang +4 more | 2022-11-15 |
| 11414392 | [6,6] fused bicyclic HDAC8 inhibitors | Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Mary-Margaret Zablocki, Bingsong Han +4 more | 2022-08-16 |
| 11396513 | Compositions for activating pyruvate kinase | Xiaozhang Zheng, Neal Green, Gary Gustafson, Lorna Helen Mitchell, Tatiana Shelekhin | 2022-07-26 |
| 11345672 | Methods using HDAC11 inhibitors | Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more | 2022-05-31 |
| 11325917 | Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors | David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, Hongbin Li +6 more | 2022-05-10 |
| 11279681 | 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors | Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more | 2022-03-22 |
| 11274084 | 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors | Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more | 2022-03-15 |
| 11274085 | 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors | Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more | 2022-03-15 |